Optiscan Imaging Ltd (ASX:OIL) Advances Robotic Surgery Collaboration with Mayo Clinic
Optiscan Imaging Ltd (ASX:OIL) advances its collaboration with Mayo Clinic to develop advanced imaging systems for robotic surgery.
Category: Industrials
Bio-Gene Technology Limited (ASX:BGT) Launches Share Purchase Plan
Bio-Gene Technology Limited (ASX:BGT) launches a Share Purchase Plan (SPP) allowing shareholders to purchase up to $15,000 in shares with complimentary options.
AdNeo Limited (ASX: AD1) Acquires Learnt Global Group and Secures Equity Commitments
AdNeo Limited (ASX: AD1) acquires Learnt Global Group and secures $1.5m in equity commitments to drive revenue growth.
Ainsworth Game Technology Limited (ASX:AGI) Announces H1CY25 Trading Update
Ainsworth Game Technology Limited (ASX:AGI) releases its H1CY25 trading update, reporting steady profits and growth in Australian revenue.
Chrysos Corporation Limited (ASX:C79) Signs Master Services Agreement with Newmont Corporation
Chrysos Corporation Limited (ASX:C79) enters into a Master Services Agreement with Newmont Corporation for its PhotonAssay technology.
Orthocell Limited (ASX:OCC) Accelerates US Remplir™ Sales Rollout with 12 Distributors
Orthocell Limited (ASX:OCC) accelerates Remplir™ sales rollout with 12 US distributors, surpassing targets and setting the stage for first sales.
Smartgroup Corporation Ltd (ASX:SIQ) Reports 10% Revenue Growth in Q1 2025
Smartgroup Corporation Ltd (ASX:SIQ) reports a 10% revenue increase in Q1 2025, driven by strong novated leasing demand and strategic partnerships.
Spectur Limited (ASX:SP3) Appoints New CEO and Reports Strong Revenue Growth
Spectur Limited (ASX:SP3) appoints Anthony Schmidt as CEO and reports over $7M revenue for FY2023, highlighting strong growth and strategic expansion.
Transurban Group (ASX:TCL) Announces Organisational Changes
Transurban Group (ASX:TCL) announces organisational changes to enhance efficiency and achieve over $50 million in cost savings.
SciDev Limited (ASX:SDV) Reports Q3 FY25 Financial Results
SciDev Limited (ASX:SDV) reports Q3 FY25 revenue up 10% and EBITDA up 200%, highlighting strategic expansion and new contracts.